InvestSMART

Recce Pharmaceuticals Ltd (ASX: RCE) - Announcements

Current share price for RCE : $0.375 0.01 (2.60%)+

ASX company news and announcements for Recce Pharmaceuticals Ltd (RCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Recce Pharmaceuticals Ltd (RCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Recce Pharmaceuticals Ltd (RCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Recce Pharmaceuticals Ltd (RCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$115 Appendix 4C - quarterly 27 Apr 2016 8:24AM $0.185 $0.375 risen by 102.70%
$115 Final Directors Interest Notice 11 Apr 2016 4:23PM $0.280 $0.375 risen by 33.93%
$115 Progress Update 11 Apr 2016 8:27AM $0.275 $0.375 risen by 36.36%
$115 International Trade Mark Registrations 6 Apr 2016 8:23AM $0.270 $0.375 risen by 38.89%
$115 Anti-cancer Activities 14 Mar 2016 8:22AM $0.240 $0.375 risen by 56.25%
$115 Amendment to Appendix 3B 29 Feb 2016 7:59PM $0.280 $0.375 risen by 33.93%
$115 Appendix 4D and Half Year Financial Statements 26 Feb 2016 7:18PM $0.285 $0.375 risen by 31.58%
$115 Becoming a substantial holder 17 Feb 2016 3:33PM $0.335 $0.375 risen by 11.94%
$115 Change of Director's Interest Notice 16 Feb 2016 7:32PM $0.335 $0.375 risen by 11.94%
$115 Appendix 3B 16 Feb 2016 6:44PM $0.335 $0.375 risen by 11.94%
$115 Conversion of Performance Shares 16 Feb 2016 3:38PM $0.350 $0.375 risen by 7.14%
$115 Efficacy without Toxicity 2 Feb 2016 8:25AM $0.380 $0.375 fallen by 1.32%
$115 Appendix 4C - quarterly 29 Jan 2016 12:51PM $0.420 $0.375 fallen by 10.71%
$115 Becoming a substantial holder 28 Jan 2016 1:23PM $0.425 $0.375 fallen by 11.76%
$115 RECCE Antibiotic kills TB and Gonorrhoea 27 Jan 2016 8:24AM $0.395 $0.375 fallen by 5.06%
$115 Becoming a substantial holder 25 Jan 2016 3:15PM $0.380 $0.375 fallen by 1.32%
$115 Becoming a substantial holder 25 Jan 2016 3:13PM $0.380 $0.375 fallen by 1.32%
$115 Broker Presentation 18 Jan 2016 1:17PM $0.325 $0.375 risen by 15.38%
$115 Initial Director's Interest Notice 15 Jan 2016 12:28PM n/a $0.375 n/a
$115 Initial Director's Interest Notice 15 Jan 2016 12:28PM n/a $0.375 n/a
$115 Initial Director's Interest Notice 15 Jan 2016 12:27PM n/a $0.375 n/a
$115 Initial Director's Interest Notice 15 Jan 2016 12:27PM n/a $0.375 n/a
$115 Initial Director's Interest Notice 15 Jan 2016 12:26PM n/a $0.375 n/a
$115 RECCE Antiobiotic Equal/Better than Commercial Antibiotic 15 Jan 2016 11:47AM n/a $0.375 n/a
$115 RECCE Trademark Registered 15 Jan 2016 11:37AM n/a $0.375 n/a

676 - 700 of 724 results

Page 28 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.